“…Thirteen other immunohistochemical markers were studied, most commonly the proliferation marker Ki67 ( 4 , 7 , 24 , 30 , 31 , 40 – 43 , 48 , 52 , 54 , 57 , 58 , 60 – 62 ). On average a cut-off at 20.9% (range: 5–30%) for high Ki67 staining was used and it was significantly associated with worse survival in 8/12 studies, of which two studies showed an independent association (HR 2.4, 95% CI: 1.1–4.9 and HR 10.2, 95% CI: 3.6–32.1) ( 28 , 30 ).…”